Stay updated on Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s revision tag was updated to v3.6.3, replacing the previous v3.6.2, indicating a newer version of the page.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page revision has been updated from v3.6.0 to v3.6.2. This indicates a newer version of the page was published.SummaryDifference0.1%

- Check33 days agoChange DetectedThe Study Details page now displays a 'No longer looking for participants' notice and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a new Revision: v3.6.0 entry. The 'Intervention/Treatment' heading and the earlier 'Revision: v3.5.5' entry have been removed.SummaryDifference0.5%

- Check40 days agoChange DetectedThe study record’s revision label was updated to v3.5.5, reflecting an editorial update to the page. The previous revision label v3.5.4 was replaced.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a version update for the page's content or UI.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s displayed revision/version number in the footer was updated from v3.5.2 to v3.5.3, reflecting a minor site release update without altering the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.